Skip to main content
Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.941
+0.021 (1.09%)
At close: Nov 13, 2026, 4:00 PM EST
1.920
-0.021 (-1.08%)
After-hours: Nov 13, 2026, 7:30 PM EST

Propanc Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
-22.61-18.86-58.92-1.82-2.66-2.66
Depreciation & Amortization
0.030.020.020.020.020.01
Other Amortization
0.060.210.30.290.20.05
Stock-Based Compensation
16.5413.5755.97-0.140.39
Other Operating Activities
0.05-0.041.090.150.720.61
Change in Accounts Payable
0.03-0.180.190.240.080.02
Change in Other Net Operating Assets
0.2-0.40.950.180.390.15
Operating Cash Flow
-5.71-5.68-0.41-0.94-1.11-1.44
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
-0-0----
Investing Cash Flow
-0-0----

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Short-Term Debt Issued
-0.180.540.840.590.77
Long-Term Debt Issued
-0.080.340.22--
Total Debt Issued
-0.250.891.060.590.77
Short-Term Debt Repaid
--0.88-0.13-0.14--
Long-Term Debt Repaid
--0.19----
Total Debt Repaid
-0.13-1.06-0.13-0.14--
Net Debt Issued (Repaid)
-0.13-0.810.760.920.590.77
Issuance of Common Stock
56.31-0.020.520.72
Other Financing Activities
0.02--0.26---
Financing Cash Flow
5.336.460.490.941.111.49

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Foreign Exchange Rate Adjustments
0.040.05-0.090-0-0.05
Net Cash Flow
-0.340.82-0.010.010.010

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-5.72-5.69-0.41-0.94-1.11-1.44
Free Cash Flow Growth
------
Free Cash Flow Per Share
-20.73-50.61-25.53---
Levered Free Cash Flow
0.111.6612.9-0.78-0.51-1.5
Unlevered Free Cash Flow
0.141.7212.95-0.66-0.38-1.19

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash Interest Paid
0.040.130.030.0100
Change in Working Capital
0.23-0.581.140.420.470.17